 The secondary purpose of this study is to determine the effect of SRT2104 0.25, 0.5, 1.0, and 2.0 gday when administered once daily for 28 consecutive days on fasting blood glucose and insulin and post-prandial blood glucose and insulin in type 2 diabetic subjects. 